Eloxx Pharmaceuticals
ELOX · OTC
$13.22+$0.72 (+5.76%)TodayMarket closed ·
Prev close $12.50
Who owns ELOX
Largest institutional holders, from their latest 13F filings
| Holder | Shares | % of shares |
|---|---|---|
| Domicilium Capital Partners LLC | 854.97K | 21.16% |
| Samsara BioCapital, LLC | 400.00K | 9.90% |
| Invus Public Equities Advisors, LLC | 400.00K | 9.90% |
| Aberdeen Group plc | 400.00K | 9.90% |
| EcoR1 Capital, LLC | 400.00K | 9.90% |
| Nantahala Capital Management, LLC | 400.00K | 9.90% |
| abrdn Inc. | 400.00K | 9.90% |
| Stonepine Capital Management, LLC | 397.16K | 9.83% |
| Coastlands Capital LP | 337.43K | 8.35% |
| Aggarwal (Sumit) | 188.66K | 4.67% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 57.48K | 1.42% |
| Vanguard Extended Market Index Fund | 19.29K | 0.48% |
| Fidelity NASDAQ Composite Index Fund | 2.29K | 0.06% |
| Vanguard Balanced Index Fund | 1.04K | 0.03% |
| Vanguard Institutional Total Stock Market Index Fund | 877 | 0.02% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ELOX in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Domicilium Real Estate Fund III LP | Other | 361.58K | — |
| Domicilium Real Estate Fund III LP | Other | 238.42K | — |
| Domicilium Real Estate Fund III LP | Other | 361.58K | — |
| Domicilium Real Estate Fund III LP | Other | 238.42K | — |
| Aggarwal Sumit | Award | 328.83K | — |
| Webster Stephen W | Award | 13.59K | — |
| Walts Alan Edmund | Award | 8.59K | — |
| Kjellson Nina S | Award | 13.59K | — |
| Rubin Steven D | Award | 4.02K | — |
| Domicilium Real Estate Fund III LP | Other | 113.64K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 53.94K
- Days to cover
- 2.42
- % of shares outstanding
- 1.34%
- Average daily volume
- 22.24K
- Change since last report
- +18.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.